King Charles will host some of the world’s most powerful artificial intelligence executives at Dumfries House in Ayrshire, Scotland, on Thursday to address mounting concerns over AI development. The gathering will bring
More
Automated cell therapy manufacturing specialist Cellares is joining forces with Taiwanese biotech GenomeFrontier Therapeutics to advance virus-free CAR-T production. The partnership will assess whether GenomeFrontier’s virus-free manufacturing process is compatible with Cellares’
More
HDA’s Kala Shankle is addressing one of the most pressing open questions in pharmaceutical distribution: what national licensure will mean for wholesalers and third-party logistics providers. Shankle, speaking to the biggest unresolved
More
Growth equity has established itself as one of the most resilient corners of private markets, drawing significant capital even as other strategies struggle with expensive debt and cautious lenders. Funds focused on
More
China’s Top Court Orders RMB 800,000 Payout To Biosimilar Patent Inventor In Landmark Profit-Sharing Ruling China’s Supreme People’s Court has issued a significant final judgment clarifying how employers must calculate and pay
More
The Federal Circuit suspended Judge Pauline Newman from hearing cases in 2023, and that order has been renewed every year since, with a fourth renewal window now open. Judge Newman is 99
More
Next (NXT) has lifted its full-year profit forecast for the fourth time in 2026, crediting an “unexpected” boost from unusually warm summer weather across the UK. The FTSE 100 retailer raised its
More
Among the fastest-growing sectors in global markets, artificial intelligence applied to healthcare continues to attract significant institutional and retail investor attention in 2026. The convergence of machine learning, diagnostics, drug discovery, and
More
The Bank of England is widely expected to leave its 3.75% Bank Rate unchanged on Thursday, even as inflation climbs well above its 2% target. Markets are pricing in more than an
More
The FTSE 250 index is home to dozens of income-generating stocks, but few manage to combine a high yield with genuine prospects for future dividend growth. A 6% dividend yield stands well
More